These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27776827)

  • 1. Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation.
    Cozzi G; Lega S; Giorgi R; Barbi E
    Ann Emerg Med; 2017 Jan; 69(1):125-127. PubMed ID: 27776827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different doses of intranasal dexmedetomidine on preoperative sedation and postoperative agitation in pediatric with total intravenous anesthesia undergoing adenoidectomy with or without tonsillectomy.
    Li LQ; Wang C; Xu HY; Lu HL; Zhang HZ
    Medicine (Baltimore); 2018 Sep; 97(39):e12140. PubMed ID: 30278489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of premedication with intranasal dexmedetomidine on inhalational induction and postoperative emergence agitation in pediatric undergoing cataract surgery with sevoflurane.
    Lin Y; Chen Y; Huang J; Chen H; Shen W; Guo W; Chen Q; Ling H; Gan X
    J Clin Anesth; 2016 Sep; 33():289-95. PubMed ID: 27555179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative sedation: An option for the management of agitation in moderate traumatic brain injury.
    Godoy DA; Tolosa K; Lubillo-Montenegro S; Murillo-Cabezas F
    Med Intensiva; 2017 Apr; 41(3):193-196. PubMed ID: 27085767
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of oral midazolam with intranasal dexmedetomidine premedication for children undergoing CT imaging: a randomized, double-blind, and controlled study.
    Ghai B; Jain K; Saxena AK; Bhatia N; Sodhi KS
    Paediatr Anaesth; 2017 Jan; 27(1):37-44. PubMed ID: 27734549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
    Narang P; Ianovich F; Sarai SK; Lippmann S
    J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
    Abe A; Takeda Y; Ishiki H
    JAMA; 2022 Jul; 328(2):213. PubMed ID: 35819432
    [No Abstract]   [Full Text] [Related]  

  • 8. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
    Henry PH; Dantz B
    JAMA; 2022 Jul; 328(2):213-214. PubMed ID: 35819431
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients.
    Shehabi Y; Nakae H; Hammond N; Bass F; Nicholson L; Chen J
    Anaesth Intensive Care; 2010 Jan; 38(1):82-90. PubMed ID: 20191782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine.
    Cohen MB; Stewart JT
    J ECT; 2013 Jun; 29(2):e23-4. PubMed ID: 23519222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine for transport of a spontaneously breathing combative child.
    Watt KM; Walgos J; Cheifetz IM; Turner DA
    Pediatrics; 2012 Sep; 130(3):e690-4. PubMed ID: 22891226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.
    Preskorn SH; Risinger R; Kakar R
    JAMA; 2022 Jul; 328(2):214-215. PubMed ID: 35819427
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation.
    Brydges D; Tibrewal P; Waite S; Dhillon R
    Aust N Z J Psychiatry; 2016 Apr; 50(4):386-7. PubMed ID: 26508796
    [No Abstract]   [Full Text] [Related]  

  • 14. Intranasal Lorazepam for Treatment of Severe Agitation in a Pediatric Behavioral Health Patient in the Emergency Department.
    Bregstein JS; Wagh AM; Tsze DS
    Ann Emerg Med; 2020 Jan; 75(1):86-89. PubMed ID: 31280921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.
    Anger KE
    Curr Pharm Des; 2013; 19(22):4003-13. PubMed ID: 23228319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Median effective dose of intranasal dexmedetomidine sedation for transthoracic echocardiography in pediatric patients with noncyanotic congenital heart disease: An up-and-down sequential allocation trial.
    Yu Q; Liu Y; Sun M; Zhang J; Zhao Y; Liu F; Li S; Tu S
    Paediatr Anaesth; 2017 Nov; 27(11):1108-1114. PubMed ID: 28940686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine Infusion may Cause Agitation During Procedural Sedation.
    Banik S; Rath GP; Huygen FJ
    Pain Pract; 2016 Jun; 16(5):E89. PubMed ID: 27260117
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury.
    Tang JF; Chen PL; Tang EJ; May TA; Stiver SI
    Neurocrit Care; 2011 Aug; 15(1):175-81. PubMed ID: 20198514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating agitation with dexmedetomidine in the ICU.
    Boyer J
    Dimens Crit Care Nurs; 2009; 28(3):102-9. PubMed ID: 19387269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial.
    Sheta SA; Al-Sarheed MA; Abdelhalim AA
    Paediatr Anaesth; 2014 Feb; 24(2):181-9. PubMed ID: 24237879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.